Feb 11, 2020   SOURCE: PR NewsWire

Global Hyperkalemia Market Report 2020; Forecast to 2022 - Featuring Profiles of Ardelyx, Astrazeneca, and Vifor Pharma

DUBLIN, Feb. 11, 2020 /PRNewswire/ -- The "Hyperkalemia Market" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This report provides exposure to the hyperkalemia market. The report also highlights current and future market potential along with a detailed analysis of the competitive environment, technological advancements and dynamics such as market drivers and factors restraining market growth.

The report also covers market projections through 2022 and includes company profiles. The report details segments such as mild, moderate and severe hyperkalemia. For market estimates, data have been provided for 2018 as the base year, along with 2019 and 2022.

The report includes:

    --  An overview of emerging markets for hyperkalemia
    --  A look at the symptoms, available treatment options and briefing about
        initial investments done for R&D
    --  Description of products included, and a detailed analysis of the markets
        and market opportunities
    --  Information on significant products categories, issues and trends,
        market influences, regulatory issues and other information affecting the
        industry
    --  Brief description of major drivers and regional dynamics of the market
        and current trends within the industry

Key Topics Covered

Table of Contents

Chapter 1 Introduction

    --  Study Goals and Objectives
    --  Reasons for Doing This Study
    --  Scope of Report
    --  Information Sources
    --  Methodology

Chapter 2 Summary and Highlights

    --  Highlights

Chapter 3 Disease Background and Market Dynamics

    --  Disease Background
    --  Overview
    --  Pathogenesis
    --  Diagnosis
    --  Epidemiology
    --  Treatment
    --  Market Dynamics
    --  Market Drivers
    --  Market Restraints

Chapter 4 Market Breakdown by Severity (Market Size and Forecast)

    --  Mild Hyperkalemia
    --  Moderate Hyperkalemia
    --  Severe Hyperkalemia

Chapter 5 Company Profiles

    --  Ardelyx
    --  Astrazeneca PLC
    --  Vifor Pharma

List of Tables
Summary Table: Global Hyperkalemia Market, by Severity, Through 2022
Table 1: Global Hyperkalemia Market, Through 2022
Table 2: Global Hyperkalemia Market, by Severity, Through 2022

List of Figures
Summary Figure: Global Hyperkalemia Market Share, by Severity, 2018
Figure 1: Global Hyperkalemia Market Share, by Severity, 2018
Figure 2: Global Mild Hyperkalemia Market, 2018-2022
Figure 3: Global Moderate Hyperkalemia Market, 2018-2022
Figure 4: Global Severe Hyperkalemia Market, 2018-2022

For more information about this report visit https://www.researchandmarkets.com/r/iegchf

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-hyperkalemia-market-report-2020-forecast-to-2022---featuring-profiles-of-ardelyx-astrazeneca-and-vifor-pharma-301002913.html

SOURCE Research and Markets